Sunhawk Vision Biotech, Inc. (TPEX:7759)

Taiwan · Delayed Price · Currency is TWD

30.35

+0.40 (1.34%)

At close: Aug 25, 2026

-56.89% (1Y)

Market Cap	2.13B -56.3%
Revenue (ttm)	n/a
Net Income	-131.82M
EPS	-1.89
Shares Out	70.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,782
Open	30.50
Previous Close	29.95
Day's Range	29.00 - 30.50
52-Week Range	25.60 - 83.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Sunhawk Vision Biotech

Sunhawk Vision Biotech, Inc., a drug development company, engages in the research and development of children's myopia eye drops, dry eye drops, and other nucleic acid new drugs for the treatment of ocular surface diseases in Taiwan. The company develops SHJ002 eye drops, which have completed a Phase 2 clinical trial for the treatment of dry eye disease in adult patients and corneal erosion in patients with Sjogren’s syndrome, as well as in a Phase 2 clinical trial for myopia control in young children. Sunhawk Vision Biotech, Inc. was founded i... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2019

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 7759

Full Company Profile

Financial Performance

Financial Statements